A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse by McSweeney, M.D., Wessler, T., Price, L.S.L., Ciociola, E.C., Herity, L.B., Piscitelli, J.A., Zamboni, W.C., Forest, M.G., Cao, Y., Lai, S.K.

Get full text

Phase I study of intravenous (IV) oxaliplatin and intraperitoneal (IP) docetaxel in recurrent ovarian and primary peritoneal cancer by Taylor, S.E, Li, R, Petschauer, J.S, Donovan, H.D, Zamboni, W.C, Edwards, R.P, Zorn, K.K

Get full text

59 Relationship Between Interspecies Variability in the Mononuclear Phagocyte System and Nanoparticle Pharmacokinetics by Caron, W.P, Lay, J.C, Santos, C, Merricks, E.P, Nichols, T.C, Ramanathan, R.K, Gehrig, P.A, Zamboni, W.C

Get full text

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tu... by Duska, L.R., Krasner, C.N., O'Malley, D.M., Hays, J.L., Modesitt, S.C., Mathews, C.A., Moore, K.N., Thaker, P.H., Miller, A., Purdy, C., Zamboni, W.C., Lucas, A.T., Supko, J.G., Schilder, R.J.

Get full text

Pitfalls of the application of microdialysis in clinical oncology: Controversial findings with docetaxel by Loos, W.J., Zamboni, W.C., Engels, F.K., de Bruijn, P., Lam, M.H., de Wit, R., Verweij, J., Wiemer, E.A.C.

Get full text